Probiotic-derived peptides are bioactive compounds produced by beneficial bacteria. These peptides can exhibit various health-promoting properties, including antimicrobial, anti-inflammatory, and antioxidant activities. They have the potential to target specific cellular pathways and exert beneficial effects on the body. Research suggests that probiotic-derived peptides may be involved in regulating immune function, improving gut health, and promoting overall well-being. While more research is needed to fully understand the mechanisms of action and potential benefits of probiotic-derived peptides, they hold promise as novel therapeutic agents for various health conditions.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India